Neuropsychiatric Disease and Treatment (May 2013)

Association between leptin and delirium in elderly inpatients

  • Sanchez JC,
  • Ospina JP,
  • Gonzalez MI

Journal volume & issue
Vol. 2013, no. default
pp. 659 – 666

Abstract

Read online

Julio C Sánchez, Jenny P Ospina, Martha I GonzálezCell and Applied Physiology Group, Department of Basic Sciences, Faculty of Health, Universidad Tecnológica de Pereira, Pereira, ColombiaAbstract: Leptin is a hormone with significant effects on the brain, both at the cellular level and cognitive level. This study aimed to establish the association between leptin levels and delirium in a Colombian elderly population. 115 patients older than 60 years were included. Leptin was measured by enzyme-linked immunosorbent assay after overnight fasting and Mini-Mental State Examination and Confusion Assessment Method (CAM) tests were employed. Delirium was diagnosed using CAM in 23.48% of patients, being most frequent in men. There were no significant differences in hematology and renal test values between patients with delirium and those without delirium, but cerebrovascular diagnoses were more frequent in patients with delirium. No correlation with any specific medication was found, but patients with delirium had a higher number of comorbidities and medications. Leptin levels were significantly lower in patients with delirium and correlated negatively with the number of diagnoses and medications, but not with age, gender, body mass index, or hematology and renal test results. Leptin levels may have a role in the pathophysiological process of delirium and low leptin could be a useful clinical biomarker to establish risk in elderly patients given the association with delirium.Keywords: delirium, elderly, hospitalization, leptin